Be The Match BioTherapies logo

Be The Match BioTherapies

North America, Minnesota, United States, Minneapolis

Description

Be The Match BioTherapies® is built on the foundation established by our parent company.

Investor Profile

Be The Match BioTherapies has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Therapeutics, Genetics.

Stage Focus

  • Series B (40%)
  • Series A (40%)
  • Series C (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Genetics
  • Health Care
  • Manufacturing
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Be The Match BioTherapies frequently co-invest with?

Access Industries
North America, New York, United States, New York
Co-Investments: 2
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 1
Gilead Sciences
North America, California, United States, Foster City
Co-Investments: 3
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
Parker Institute for Cancer Immunotherapy
North America, California, United States, San Francisco
Co-Investments: 2
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Ping An Ventures
Asia, Shandong, China, Pudong
Co-Investments: 2
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
University of Pennsylvania
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 2

What are some of recent deals done by Be The Match BioTherapies?

Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series BOct 31, 2019
Amount Raised: $75,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AApr 19, 2018
Amount Raised: $35,000,000
Magenta Therapeutics

Cambridge, Massachusetts, United States

Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.

BiotechnologyMedicalTherapeutics
Series CApr 9, 2018
Amount Raised: $52,000,000
Tmunity Therapeutics

Philadelphia, Pennsylvania, United States

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells.

BiotechnologyGeneticsHealth CareManufacturingTherapeutics
Series AJan 23, 2018
Amount Raised: $100,000,000
Magenta Therapeutics

Cambridge, Massachusetts, United States

Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.

BiotechnologyMedicalTherapeutics
Series BMay 2, 2017
Amount Raised: $50,000,000

Find More Investors Like Be The Match BioTherapies

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Be The Match BioTherapies | Pipeseed